Vendor, Menlo Park, CA
AN2 Therapeutics, Inc.
UEI DD4FE2GE4L78, CAGE 822Z2
1 award and $4,278,131 obligated between March 1, 2024 and August 18, 2026, 100% under full and open competition, against 30.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $4,278,131 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Hear when AN2 Therapeutics, Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts AN2 Therapeutics, Inc. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 1
- Obligated so far
- $4,278,131
- Soonest
- July 31, 2027
The 1 contract, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) to National Institutes of Health, by dollars.
| Leidos Biomedical Research Inc.Frederick, MD | $2,186,369,442 |
| Westat, Inc.Rockville, MD | $760,724,225 |
| Technical Resources International, Inc.Bethesda, MD | $196,391,189 |
| Duke UniversityDurham, NC | $158,758,507 |
| MriglobalKansas City, MO | $117,921,746 |
| The Johns Hopkins UniversityBaltimore, MD | $100,932,043 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93022C00059Definitive Contract, March 1, 2024, Full and Open Competition, 30 offers | National Institutes of Health NiaidNational Institutes of Health | Development of Epetraborole as a Novel Therapeutic for Melioidosis and Additional Antimicrobial Resistant (Amr) Bacterial Biothreat PathogenNAICS 541715, PSC AN12 | $4,278,131 |
- Places of performance
- California
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 9 across 1 awards